Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium sodium hydrogen citrate sensitivity study in uric acid kidney stones
ChiCTR2300077586Phase 4Recruiting
- Sponsor
- Affiliated Changshu Hospital of Nantong University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of potassium sodium hydrogen citrate in uric acid lithiasis and Lithiasis (2 arms), sponsored by Affiliated Changshu Hospital of Nantong University. Primary endpoints: Gut microbiota, Fecal short-chain fatty acid contents and 1 more. Started Jul 2021; status: recruiting.
02
Drugs
potassium sodium hydrogen citrate
03
Conditions
uric acid lithiasisLithiasis
Beyond the preview
Go deeper on ChiCTR2300077586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077586.